06/09/2025
5:05 AM | Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
8:04 AM | DePinho Ronald A (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/27/2025
7:09 AM | Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
3:20 PM | Tvardi Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K/A | |
05/02/2025
5:12 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4/A | |
05/02/2025
5:19 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4/A | |
05/02/2025
3:21 PM | Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Tweardy David John (Filed by)
| Form SCHEDULE 13G | |
04/22/2025
1:26 PM | Solas Tvardi Sidecar LLC (Filed by)
Tvardi Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/21/2025
4:15 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TVRD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
4:15 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Shiff Susan Ph.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:15 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:50 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
5:19 PM | Shah Sujal (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:22 PM | Conn Avi Daniel (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:24 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Wirk Shaheen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:26 PM | HALL WALLACE L JR (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:28 PM | Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
WYZGA MICHAEL S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:30 PM | O'Brien Stephen Paul (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:05 PM | Larson Jeffrey Leroy (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:08 PM | Chen Yixin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:11 PM | Smith Cynthia (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:13 PM | Alibhai Imran Nizamudin (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/17/2025
5:16 PM | Kauh John Saewook M.D. (Reporting)
Tvardi Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Trump’s national nightmare is here (Ad) The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washington… even Trump’s obsession with seizing Greenland.
There’s a singular force that connects the dots…
And it could threaten to transform American life – and your wealth – forever.  You can get all the details here. |
04/11/2025
3:16 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
3:30 PM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form 425 | |
02/17/2025
11:15 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:13 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 424B3 | |
02/14/2025
5:01 AM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form S-4/A | |
02/06/2025
6:15 PM | Cara Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:19 AM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form S-4/A | |
01/21/2025
7:50 AM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
7:53 AM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form 425 | |
01/17/2025
3:43 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
3:44 PM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:02 PM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:01 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:10 PM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SCHEDULE 13D/A | |
12/18/2024
3:26 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/18/2024
6:23 AM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
6:25 AM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form 425 | |
11/22/2024
3:09 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:51 PM | Cara Therapeutics, Inc. (Issuer)
Tvardi Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:21 PM | Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SC 13D | |
08/01/2024
3:15 PM | Cara Therapeutics, Inc. (Filer)
Tvardi Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Cara Therapeutics, Inc. (Subject)
Tvardi Therapeutics (Subject)
| Form SC 13G/A | |
Buy TVRD Stock Free TVRD Stock Alerts